Zaurategrast
id:
zaurategrast-238-10186107
title:
Zaurategrast
text:
Zaurategrast (CDP323) is a small-molecule prodrug antagonist of the vascular cell adhesion molecule 1 (VCAM-1) binding to α4-integrins. It was originally developed by the British biopharmaceutical company Celltech plc. and was a putative new drug for oral treatment of multiple sclerosis. In October 2006, UCB and Biogen Idec announced a collaboration to jointly develop and commercialize zaurategrast for the treatment of multiple sclerosis and other potential indications. In June 2009, development
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Zaurategrast
date created:
date modified:
2023-03-11T00:37:07Z
main entity:
{"identifier":"Q166806","url":"https://www.wikidata.org/entity/Q166806"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1b/Zaurategrast.svg","width":1603,"height":864}
fields total:
13
integrity:
15